DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Fox RJ, Cree BA, De Seze J et al.
MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.
Neurology 2014;
82: 1491-1498
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.